Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-02 Option Award |
2024-01-04 4:22 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
52,575 | $1.32 | 122,575 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:22 pm |
N/A 2034-01-02 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
35,000 | $0 | 122,575 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:14 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
35,000 | $0 | 110,500 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:14 pm |
N/A 2033-01-03 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
40,500 | $1.67 | 110,500 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:05 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
47,872 | $1.13 | 97,872 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:05 pm |
N/A 2032-01-03 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
25,000 | $0 | 97,872 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 5:55 pm |
2021-12-31 2031-02-19 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
25,000 | $0 | 238,340 (Direct) |
View |
Ownership |
2020-09-18 4:14 pm |
N/A 2030-07-13 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
0 | $0 | 213,340 (Direct) |
View |